Development and characterization of sorafenib-loaded PLGA nanoparticles for the systemic treatment of liver fibrosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development and characterization of sorafenib-loaded PLGA nanoparticles for the systemic treatment of liver fibrosis

Published:2016-01 Issue: Volume:221 Page:62-70
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Lin Ts-Ting,Gao Dong-Yu,Liu Ya-Chi,Sung Yun-Chieh,Wan Dehui,Liu Jia-Yu,Chiang Tsaiyu,Wang Liying,Chen Yunching

Funder

NSC

MOST

Chang Gung Memorial Hospital—National Tsing Hua University Joint Research

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference32 articles.

1. Mechanisms of hepatic fibrogenesis;Friedman;Gastroenterology,2008

2. Angiogenesis in liver disease;Fernandez;J. Hepatol.,2009

3. Chemokine Cxcl9 attenuates liver fibrosis-associated angiogenesis in mice;Sahin;Hepatology,2012

4. Myofibroblast-like cells and liver fibrogenesis: emerging concepts in a rapidly moving scenario;Parola;Mol. Asp. Med.,2008

5. Hepatic stellate cells secrete angiopoietin 1 that induces angiogenesis in liver fibrosis;Taura;Gastroenterology,2008

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual-targeting galactose-functionalized hyaluronic acid modified lipid nanoparticles delivering silybin for alleviating alcoholic liver injury;International Journal of Pharmaceutics;2024-09

2. Enhanced anti-angiogenic effects of aprepitant-loaded nanoparticles in human umbilical vein endothelial cells;Scientific Reports;2024-08-27

3. Application of PPAR Ligands and Nanoparticle Technology in Metabolic Steatohepatitis Treatment;Biomedicines;2024-08-16

4. Investigation of magnesium aluminometasilicate (Neusilin US2) based surface solid dispersion of sorafenib tosylate using QbD approach: In vitro and in vivo pharmacokinetic study;ADMET and DMPK;2024-08-09

5. Erythrocyte membrane-camouflaged mesoporous silica composite nanoparticles for loading and controlled release of the hepatoprotective agent silibinin: A-synthesis and physicochemical characterization;Journal of Pharmacy and Pharmacology;2024-05-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3